Justine is focused on integrating psycho-spiritual care, including psychedelic therapies, into oncology and palliative care settings, to help reduce existential and spiritual distress and improve quality of life. 

Presently, she is working Dr Lauren MacDonald and Mind Medicine Australia to expand the indications for psilocybin to include existential distress at end of life. 

If successful, this amendment to psilocybin’s Schedule 8 classification will allow specialist palliative care physicians who become authorised prescribers under the Therapeutic Goods Administration’s Authorised Prescriber (AP) Scheme to prescribe psilocybin as part of therapy for patients suffering from existential distress at end of life. 

Her core values are to honour and advocate for options and choice for all at end-of-life. She foresees a day when patients are able to step away from the impositions, traditions and negative stigma around both death and psychedelics, and embrace personal choice as the chapter of life comes to an end.

The Ethics Center, Sydney, will host Justine and Lauren in residence in June 2024. They will be in conversation with ethicists, lawmakers, doctors and other end-of-life practitioners. The project aims to challenge and empower the societal rhetoric about end-of-life choices. Join them in this important public dialogue.